An optimized method to assess in vivo efficacy of antithrombotic drugs using optical coherence tomography and a modified Doppler flow system

Journal of Pharmacological and Toxicological Methods

Volumn 64, Issue 3, 2011, Pages 264-268

  Couture, L ^a   Richer, L P ^a   Cadieux, C ^a   Thomson, C M ^a   Hossain, S M ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Blood flow; Ferric chloride; Methods; Optical coherence tomography; Thrombus; Time to occlusion

Indexed keywords

ARGATROBAN; HEPARIN; HIRULOG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY THROMBOSIS; ARTICLE; BLOOD FLOWMETRY; CONTROLLED STUDY; DOPPLER FLOWMETRY; DRUG EFFICACY; IN VIVO STUDY; MALE; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PROCESS OPTIMIZATION; RAT; THROMBOGENESIS; VEIN THROMBOSIS;

ANIMALS; DRUG EVALUATION, PRECLINICAL; FIBRINOLYTIC AGENTS; HEPARIN; HIRUDINS; LASER-DOPPLER FLOWMETRY; MALE; PEPTIDE FRAGMENTS; PIPECOLIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; RENAL CIRCULATION; THROMBOSIS; TOMOGRAPHY, OPTICAL COHERENCE;

ANIMALIA; RATTUS;

EID: 81955164182     PISSN: 10568719     EISSN: 1873488X     Source Type: Journal    
DOI: 10.1016/j.vascn.2011.09.001     Document Type: Article

References (24)

1. Abramoff M.D., Magalhaes P.J., Ram S.J. Image processing with Image J. Biophotonics International 2004, 11(7):36-42.
2. 3-induced arterial thrombosis. Journal of Thrombosis and Haemostasis 2011, 9(4):779-789.
3. Fareed J., Hoppensteadt D., Iqbal O., Tobu M., Lewis B.E. Practical issues in the development of argatroban: a perspective. Pathophysiology of Haemostasis and Thrombosis 2002, 32(Suppl. 3):56-65.
4. Furie B., Furie B.C. Thrombus formation in vivo. Journal of Clinical Investigation 2005, 115(12):3355-3362.
5. Furie B., Furie B.C. Cancer-associated thrombosis. Blood Cells, Molecules & Diseases 2006, 36(2):177-181.
6. Hennan J.K., Morgan G.A., Swillo R.E., Antrilli T.M., Mugford C., Vlasuk G.P., et al. Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis. Journal of Thrombosis and Haemostasis 2008, 6(9):1558-1564.
7. Kleinbaum D.G., Kupper L.L., Nizam A., Muller K.E. Applied regression analysis and other multivariable methods 2008, Duxbury Press, North Scituate, (Chapter 4). 4th ed.
8. Kume T., Akasaka T., Kawamoto T., Ogasawara Y., Watanabe N., Toyota E., et al. Assessment of coronary arterial thrombus by optical coherence tomography. The American Journal of Cardiology 2006, 97(12):1713-1717.
9. Kume T., Akasaka T., Kawamoto T., Okura H., Watanabe N., Toyota E., et al. Measurement of the thickness of the fibrous cap by optical coherence tomography. American Heart Journal 2006, 152(4):755.e1-755.e4.
10. Kume T., Okura H., Kawamoto T., Akasaka T., Toyota E., Watanabe N., et al. Images in cardiovascular medicine. Fibrin clot visualized by optical coherence tomography. Circulation 2008, 118(4):426-427.
11. Kurz K.D., Main B.W., Sandusky G.E. Rat model of arterial thrombosis induced by ferric chloride. Thrombosis Research 1990, 60(4):269-280.
12. Leadley R.J., Chi L., Rebello S.S., Gagnon A. Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents. Journal of Pharmacological and Toxicological Methods 2000, 43(2):101-116.
13. Levi M., Schouten M., van der Poll T. Sepsis, coagulation, and antithrombin: old lessons and new insights. Seminars in Thrombosis and Hemostasis 2008, 34(8):742-746.
14. Manfrini O., Mont E., Leone O., Arbustini E., Eusebi V., Virmani R., et al. Sources of error and interpretation of plaque morphology by optical coherence tomography. The American Journal of Cardiology 2006, 98(2):156-159.
15. Meng L., Lv B., Zhang S., Yv B. In vivo optical coherence tomography of experimental thrombosis in a rabbit carotid model. Heart 2008, 94(6):777-780.
16. Nesheim M. Thrombin and fibrinolysis. Chest 2003, 124(3 Suppl.):33S-39S.
17. Popescu D.P., Flueraru C., Mao Y., Chang S., Sowa M.G. Signal attenuation and box-counting fractal analysis of optical coherence tomography images of arterial tissue. Biomedical Optics Express 2010, 1(1):268-277.
18. Randall M.J., Wilding R.I. Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with dazoxiben hydrochloride (UK 37,248-01). British Journal of Clinical Pharmacology 1983, 15(Suppl. 1):49S-55S.
19. Surin W.R., Prakash P., Barthwal M.K., Dikshit M. Optimization of ferric chloride induced thrombosis model in rats: effect of anti-platelet and anti-coagulant drugs. Journal of Pharmacological and Toxicological Methods 2010, 61(3):287-291.
20. 3 injured murine common carotid artery. Thrombosis Research 2006, 118(2):275-280.
21. Wang X. Lipopolysaccharide augments venous and arterial thrombosis in the mouse. Thrombosis Research 2008, 123(2):355-360.
22. Wang X., Xu L. An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research. Thrombosis Research 2005, 115(1-2):95-100.
23. Yabushita H., Bouma B.E., Houser S.L., Aretz H.T., Jang I.K., Schlendorf K.H., et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002, 106(13):1640-1645.
24. Zar J.H. Biostatistical analysis 1984, Prentice Hall, Englewood Cliffs, (Chapter 12). 2nd ed.